Phase 1 clinical trial for Hantavirus vaccines yields positive interim results

GOLDEN, Colo., March 13, 2018 /PRNewswire/ -- PharmaJet®, the maker of innovative, needle-free injection technology, today announced the reporting of positive interim results from the Phase 1 clinical trial conducted by the US Army Medical Research Institute of Infectious...

Leave a comment

Your email address will not be published.